These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 19262639)
1. Virus-free pluripotency for human cells. Hayden EC; Baker M Nature; 2009 Mar; 458(7234):19. PubMed ID: 19262639 [No Abstract] [Full Text] [Related]
2. Reprogrammed induced pluripotent stem cells: how suitable could they be in reproductive medicine? Ensenat-Waser R; Pellicer A; Simon C Fertil Steril; 2009 Apr; 91(4):971-4. PubMed ID: 19200985 [TBL] [Abstract][Full Text] [Related]
3. [Reprogramming human fibroblasts to pluripotent stem cells. A new paradigm in regenerative medicine]. Pusqualini CD Medicina (B Aires); 2008; 68(2):181-3. PubMed ID: 18499972 [No Abstract] [Full Text] [Related]
4. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Chang CW; Lai YS; Pawlik KM; Liu K; Sun CW; Li C; Schoeb TR; Townes TM Stem Cells; 2009 May; 27(5):1042-9. PubMed ID: 19415770 [TBL] [Abstract][Full Text] [Related]
5. Nerve cells made from elderly patient's skin cells. Baker M Nature; 2008 Aug; 454(7205):675. PubMed ID: 18685662 [No Abstract] [Full Text] [Related]
6. The reprogramming language of pluripotency. Welstead GG; Schorderet P; Boyer LA Curr Opin Genet Dev; 2008 Apr; 18(2):123-9. PubMed ID: 18356040 [TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells: reprogrammed without a trace. Nelson TJ; Terzic A Regen Med; 2009 May; 4(3):333-5. PubMed ID: 19438303 [No Abstract] [Full Text] [Related]
8. Regenerative medicine and human models of human disease. Chien KR Nature; 2008 May; 453(7193):302-5. PubMed ID: 18480810 [TBL] [Abstract][Full Text] [Related]
9. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Braam SR; Passier R; Mummery CL Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090 [TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells: an emerging theranostics platform. Nelson TJ; Terzic A Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525 [TBL] [Abstract][Full Text] [Related]
14. Hybrid embryos fail to live up to stem-cell hopes. Ledford H Nature; 2009 Feb; 457(7230):642. PubMed ID: 19205093 [No Abstract] [Full Text] [Related]
15. [Could the cell memory of a previous life be erased by reprogramming towards pluripotency?]. Lapasset L; Milhavet O; Lemaitre JM Med Sci (Paris); 2010 Nov; 26(11):902-3. PubMed ID: 21106166 [No Abstract] [Full Text] [Related]
18. The significance of induced pluripotent stem cells for basic research and clinical therapy. Meyer JR J Med Ethics; 2008 Dec; 34(12):849-51. PubMed ID: 19043107 [TBL] [Abstract][Full Text] [Related]
19. Transplantation tolerance in an age of induced pluripotency. Fairchild PJ Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888 [TBL] [Abstract][Full Text] [Related]
20. Induced human pluripotent stem cells: promises and open questions. Rolletschek A; Wobus AM Biol Chem; 2009 Sep; 390(9):845-9. PubMed ID: 19558327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]